Helmut Schumacher Selected Research

Telmisartan (Micardis)

1/2021	Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk.
1/2021	Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke.
10/2020	Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials.
1/2020	Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials.
1/2018	Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
11/2017	Relative and Combined Prognostic Importance of On-Treatment Mean and Visit-to-Visit Blood Pressure Variability in ONTARGET and TRANSCEND Patients.
6/2017	Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
3/2015	Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk.
9/2014	Telmisartan in combination with hydrochlorothiazide 12.5 mg for the management of patients with hypertension.
6/2014	Impact of telmisartan on cardiovascular outcome in hypertensive patients at high risk: a Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease subanalysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Helmut Schumacher Research Topics

Disease

15	Hypertension (High Blood Pressure) 01/2021 - 01/2002
14	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 07/2004
8	Stroke (Strokes) 01/2022 - 07/2004
6	Heart Failure 01/2022 - 07/2004
4	Myocardial Infarction 01/2022 - 07/2004
4	Vascular Diseases (Vascular Disease) 01/2021 - 04/2008
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 10/2020
3	Ischemic Stroke 07/2017 - 02/2010
3	Cough 02/2017 - 04/2008
3	Albuminuria 10/2014 - 07/2009
2	Atrial Fibrillation 01/2021 - 06/2015
2	Hemorrhage 01/2021 - 01/2020
2	Cognitive Dysfunction 03/2015 - 01/2011
2	Isolated Systolic Hypertension 01/2013 - 01/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 10/2011
2	Type 2 Diabetes Mellitus (MODY) 04/2012 - 10/2011
2	Angioedema 01/2012 - 04/2008
1	Nocturia 01/2020
1	Lower Urinary Tract Symptoms 01/2020
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2020
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2020
1	Fatigue 02/2017
1	Rhinorrhea 02/2017
1	Common Cold 02/2017
1	Fever (Fevers) 02/2017
1	Headache (Headaches) 02/2017
1	Pain (Aches) 02/2017
1	Sneezing 02/2017
1	Arthralgia (Joint Pain) 02/2017
1	Edema (Dropsy) 01/2014
1	Obesity 01/2013
1	Glucose Intolerance 09/2011
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2009
1	Proteinuria 08/2008
1	Syncope (Fainting) 04/2008
1	Essential Hypertension 11/2005
1	Pneumonia (Pneumonitis) 03/2003
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 03/2003

Drug/Important Bio-Agent (IBA)

26	Telmisartan (Micardis)FDA Link 01/2021 - 01/2002
13	Ramipril (Altace)FDA LinkGeneric 01/2021 - 07/2004
7	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 09/2014 - 01/2002
6	CreatinineIBA 01/2022 - 07/2009
5	Antihypertensive Agents (Antihypertensives)IBA 01/2013 - 01/2002
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2012 - 07/2004
4	Angiotensin Receptor AntagonistsIBA 09/2011 - 04/2008
3	Amlodipine (Norvasc)FDA LinkGeneric 01/2014 - 08/2010
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2008 - 07/2004
2	AlbuminsIBA 01/2021 - 10/2014
2	Warfarin (Coumadin)FDA LinkGeneric 01/2020 - 06/2015
2	DiureticsIBA 01/2020 - 01/2012
2	Glucose (Dextrose)FDA LinkGeneric 10/2014 - 09/2011
2	hydrochlorothiazide drug combination telmisartanIBA 06/2013 - 11/2005
2	Losartan (Cozaar)FDA LinkGeneric 11/2005 - 01/2002
1	Hypnotics and Sedatives (Sedatives)IBA 01/2020
1	Dabigatran FDA Link 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Thrombin FDA Link 01/2020
1	Tamsulosin (Flomax)FDA LinkGeneric 01/2020
1	Insulin-Like PeptidesIBA 07/2017
1	Insulin (Novolin)FDA Link 07/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 07/2017
1	Insulin-Like Growth Factor Binding Protein 3IBA 07/2017
1	Drug CombinationsIBA 02/2017
1	Ibuprofen (Motrin)FDA LinkGeneric 02/2017
1	Pseudoephedrine FDA LinkGeneric 02/2017
1	Vitamin K FDA Link 06/2015
1	telmisartan amlodipine combination FDA Link 01/2013
1	A 7 (A-7)IBA 05/2012
1	SolutionsIBA 05/2012
1	Biomarkers (Surrogate Marker)IBA 01/2012
1	Valsartan (Vals)FDA Link 01/2012
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2012
1	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2010
1	Dipyridamole (Persantine)FDA LinkGeneric 02/2010
1	Surface-Active Agents (Surfactants)IBA 03/2003
1	Therapeutic UsesIBA 01/2002

Therapy/Procedure

9	Therapeutics 01/2014 - 01/2002
1	Polypharmacy 01/2021